ATOSSA THERAPEUTICS, INC. (ATOS)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-88.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$37.14M | -$27.62M | -$31.38M | -$27.69M | -$20.52M | -$14.61M | -$17.27M | -$11.43M | -$7.65M | -$7.97M |
| Net Income | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.40M | -$8.12M | -$6.37M |
| EPS (Diluted) | $-4.04 | $-3.04 | $-0.24 | $-0.21 | $-0.18 | — | — | — | — | — |
| Total Assets | $47.61M | $76.44M | $96.25M | $123.53M | $141.26M | $42.84M | $14.49M | $11.72M | $8.16M | $4.14M |
| Total Liabilities | $8.26M | $4.97M | $5.24M | $5.57M | $3.13M | $15.67M | $1.33M | $2.92M | — | $1.05M |
| Shareholders' Equity | $39.35M | $71.48M | $91.02M | $117.96M | $138.14M | $27.17M | $13.16M | $8.81M | $6.94M | $3.10M |
| Cash & Equivalents | $41.30M | $71.08M | $88.46M | $110.89M | $136.38M | $39.55M | $12.58M | $10.38M | $7.22M | $3.03M |
| Operating Cash Flow | -$29.76M | -$21.03M | -$20.94M | -$20.76M | -$16.47M | -$11.57M | -$9.13M | -$8.96M | -$6.59M | -$5.37M |
| Capital Expenditures | $23.0K | $19.0K | $14.0K | $27.0K | $9.0K | $9.0K | $7.6K | $110.9K | — | — |
| Shares Outstanding | 8.61M | 8.61M | 125.30M | 126.62M | 126.62M | 47.55M | 9.13M | 5.85M | 2.65M | 3.79M |